ArticleOncoimmunology2012

Imatinib mesylate can help to direct natural immunity toward an anti-leukemic reactivity by acting on the bone marrow microenvironment.

Alessandro Poggi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.